ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation - 30
66808001 GlaxoSmithKline AG
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation20.09.2018
  20.09.2018
Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (R03AL08) 
WHO-DDD 
03.99.30
03.99. 
B  
Yes 
IPCI
64.92Yes
    
10 %87.00
  
7680668080014Synthetika
7589237 
Composition
fluticasoni furoas 100 µg, umeclidinium 62.5 µg ut umeclidinii bromidum, vilanterolum 25 µg ut vilanteroli trifenatas, excipiens ad pulverem pro dosi.
Packungsbestandteile
Einzeldosiertes Pulver zur Inhalation 
  
 
Active AgentDose
Fluticasoni Furoas100 µg
Umeclidinium62.5 µg
Vilanterolum25 µg
BAG: Active AgentDose
Fluticasoni Furoas92 mcg
Umeclidinium55 mcg
Vilanterolum22 mcg
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home